Global vaccine company to be set up in India
September 17th, 2009 - 7:14 pm ICT by IANSLondon, Sep 17 (IANS) In what was described as a global first, American pharmaceutical giant Merck and Britain’s largest charity, Wellcome Trust Thursday announced the formation of an India-based nonprofit company that will produce cheap vaccines for the developing world.
Hilleman Laboratories will be headed by Indian-origin medical scientist Altaf A. Lal, who currently works at the US embassy in India looking after health.
Based in Hyderabad, the first vaccine the new company will develop is against Group A streptococci, which affects 18 million people, mostly in the developing world and kills half a million people a year, Wellcome Trust director Mark Walport said.
A 2004 Indian study estimated that Group A streptococci, which causes rheumatic fever and disability, could affect up to half a million people in India every year.
- Indian pharma to be involved in $150 mn global vaccine venture - Sep 18, 2009
- Two gene variants in dengue identified - Oct 18, 2011
- First vaccine against kala azar ready for trial - Feb 22, 2012
- Anti-dengue vaccine to be ready in six years: Expert - Nov 16, 2011
- A German award to commemorate Tagore's 150 years - Jan 17, 2012
- Vaccine slashes malaria risk by half - Jan 14, 2011
- New antibiotic recommended for treating typhoid in low-income countries - Apr 29, 2011
- India-origin scientist's findings may hold key to novel malaria vaccines - Oct 22, 2010
- India capable of producing lower-cost HPV vaccine - Jul 10, 2010
- Pune firm slashes pentavalent vaccine prices 60 percent - Jun 13, 2011
- US trade group sends life sciences mission to India - Jan 31, 2012
- India to unveil second swine flu vaccine - Jul 09, 2010
- Need to sensitize society on autism - Apr 03, 2012
- Pharma firms to conduct H1N1 vaccine human trials in India - Dec 08, 2009
- US firm gets $220 mn Gates grant to combat TB - Mar 15, 2012
Tags: american pharmaceutical, charity, developing world, disability, embassy in india, group a streptococci, half a million, Health Science, indian origin, lal, london, medical scientist, merck, nonprofit company, pharmaceutical giant, rheumatic fever, us embassy in india, vaccine company, vaccines, wellcome trust
